Safety of fertility preservation techniques before and after anticancer treatments in young women with breast cancer: a systematic review and meta-analysisLuca Arecco, Matteo Lambertini, Andrea Boutros et al.|Human Reproduction|2022Cited by 105
Survival Following CDK4/6 Inhibitor Therapy for Hormone Receptor–Positive, <i>ERBB2</i>–Negative Metastatic Breast CancerPier Paolo Maria Berton Giachetti, Carmen Criscitiello, Stefania Morganti et al.|JAMA Network Open|2025Cited by 11
The evolving landscape of hormone receptor-positive/HER2-negative metastatic breast cancer (EVOLVE): An Italian Delphi consensus reportFederica Miglietta, Grazia Arpino, Maria Grazia Razeti et al.|Critical Reviews in Oncology/Hematology|2025Cited by 4